Profile data is unavailable for this security.
About the company
Aclarion, Inc. is a healthcare technology company. The Company leverages magnetic resonance spectroscopy (MRS) and proprietary biomarkers to optimize clinical treatments. The Company has developed a software application called NOCISCAN. The product uses the existing MRS capabilities of many commercially available scanners to non-invasively analyze the chemical makeup of intervertebral discs in the spine. The software post-processes the MRS exam data and detects the presence of chemical biomarkers that Aclarion, in conjunction with spine researchers at University of California San Francisco (UCSF), have demonstrated to be associated with degenerative pain and structural integrity of the lumbar discs. After processing the MRS exam data, the Company sends the ordering clinician a report that details how to interpret the results of the MRS exam. The platform used to conduct a NOCISCAN involves a diagnostic report called a Nocigram that identifies discs as painful or not.
- Revenue in USD (TTM)67.48k
- Net income in USD-7.39m
- Incorporated2008
- Employees6.00
- LocationAclarion Inc8181 Arista Place, Ste 100BROOMFIELD 80021United StatesUSA
- Phone+1 (302) 636-5401
- Fax+1 (302) 636-5454
- Websitehttps://aclarion.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synlogic Inc | 0.00 | -3.23m | 6.96m | 1.00 | -- | 0.6742 | -- | -- | -0.2625 | -0.2625 | 0.00 | 0.8826 | 0.00 | -- | -- | 0.00 | -17.30 | -44.41 | -27.54 | -50.06 | -- | -- | -- | -3,944.49 | -- | -- | 0.00 | -- | -99.76 | -67.55 | 61.88 | -- | -59.28 | -- |
| Pharmacyte Biotech Inc | 0.00 | -8.98m | 7.51m | 2.00 | -- | 0.1413 | -- | -- | -1.32 | -1.32 | 0.00 | 5.38 | 0.00 | -- | -- | 0.00 | -12.74 | 7.21 | -13.51 | 7.54 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 235.53 | -- | -- | -- |
| Alzamend Neuro Inc | 0.00 | -6.47m | 7.53m | 4.00 | -- | 1.72 | -- | -- | -5.71 | -5.71 | 0.00 | 1.15 | 0.00 | -- | -- | 0.00 | -116.49 | -171.97 | -144.76 | -256.71 | -- | -- | -- | -- | -- | -766.93 | 0.00 | -- | -- | -- | 48.68 | -- | -- | -- |
| Intelligent Bio Solutions Inc | 3.29m | -10.87m | 7.58m | 16.00 | -- | 1.57 | -- | 2.30 | -17.27 | -17.27 | 5.09 | 3.98 | 0.3025 | 2.74 | 5.08 | 205,752.50 | -100.21 | -73.55 | -191.77 | -123.30 | 43.08 | -- | -331.26 | -476.22 | 0.7618 | -- | 0.0392 | -- | -1.90 | 74.49 | -4.06 | -- | -- | -- |
| Quince Therapeutics Inc | 0.00 | -56.98m | 7.75m | 36.00 | -- | 7.16 | -- | -- | -1.22 | -1.22 | 0.00 | 0.0194 | 0.00 | -- | -- | 0.00 | -48.20 | -42.95 | -55.60 | -46.33 | -- | -- | -- | -- | -- | -- | 0.943 | -- | -- | -- | -81.07 | -- | 36.12 | -- |
| Curanex Pharmaceuticals Inc | 0.00 | -1.30m | 7.82m | -- | -- | 0.5473 | -- | -- | -0.0497 | -0.0497 | 0.00 | 0.5043 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -142.76 | 0.00 | -- | -- | -- | -1,782.87 | -- | -- | -- |
| Aclarion Inc | 67.48k | -7.39m | 7.85m | 6.00 | -- | 0.1281 | -- | 116.32 | -1,687.50 | -1,687.50 | 0.1948 | 21.46 | 0.0082 | -- | 2.76 | 11,246.67 | -89.50 | -- | -97.72 | -- | -7.85 | -- | -10,868.49 | -- | -- | -25,428.22 | 0.00 | -- | -39.36 | -- | -43.60 | -- | -- | -- |
| Theriva Biologics Inc | 0.00 | -26.19m | 7.85m | 22.00 | -- | 0.3365 | -- | -- | -5.53 | -5.53 | 0.00 | 0.6539 | 0.00 | -- | -- | 0.00 | -73.83 | -37.94 | -99.55 | -42.02 | -- | -- | -- | -- | -- | -- | 0.2025 | -- | -- | -- | -39.81 | -- | -- | -- |
| Kiora Pharmaceuticals Inc | 0.00 | -8.54m | 7.91m | 12.00 | -- | 0.3294 | -- | -- | -2.05 | -2.05 | 0.00 | 6.53 | 0.00 | -- | -- | 0.00 | -24.99 | -48.77 | -27.44 | -56.18 | -- | -- | -- | -276.73 | -- | -- | 0.00 | -- | -- | 42.93 | 127.56 | -- | -- | -- |
| Curative Biotechnology Inc | 0.00 | -6.02m | 7.94m | 4.00 | -- | -- | -- | -- | -0.0105 | -0.0105 | 0.00 | -0.0018 | 0.00 | -- | -- | 0.00 | -339.98 | -- | -- | -- | -- | -- | -- | -- | -- | -5.51 | -- | -- | -- | -- | -302.92 | -- | -- | -- |
| Transcode Therapeutics Inc | 0.00 | -27.16m | 8.17m | 7.00 | -- | 5.21 | -- | -- | -354.09 | -354.09 | 0.00 | 1.71 | 0.00 | -- | -- | 0.00 | -592.26 | -153.21 | -1,387.56 | -219.22 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 9.49 | -- | -- | -- |
| Hi-Great Group Holding Co | 48.03k | -64.27k | 8.21m | -- | -- | -- | -- | 170.94 | -0.0006 | -0.0006 | 0.0005 | -0.002 | 0.7229 | 0.5559 | -- | -- | -96.73 | -21.81 | -- | -256.35 | 38.77 | 45.63 | -133.81 | -21.02 | 0.0288 | -- | -- | -- | -36.79 | -- | 60.07 | -- | -- | -- |
| BioVie Inc | 0.00 | -18.57m | 8.52m | 13.00 | -- | 0.3418 | -- | -- | -8.92 | -8.92 | 0.00 | 3.31 | 0.00 | -- | -- | 0.00 | -76.90 | -260.69 | -93.38 | -454.45 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 45.73 | -- | -- | -- |
| Calcimedica Inc | 0.00 | -23.06m | 8.64m | 14.00 | -- | -- | -- | -- | -1.60 | -1.60 | 0.00 | -0.0188 | 0.00 | -- | -- | 0.00 | -148.18 | -58.12 | -194.91 | -64.99 | -- | -- | -- | -- | -- | -- | 1.03 | -- | -- | -- | 60.12 | -- | -57.90 | -- |
Data as of Feb 06 2026. Currency figures normalised to Aclarion Inc's reporting currency: US Dollar USD
4.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| DRW Securities LLCas of 30 Sep 2025 | 11.58k | 1.99% |
| CapFinancial Partners LLCas of 30 Sep 2025 | 10.00k | 1.72% |
| UBS Securities LLCas of 31 Dec 2025 | 1.05k | 0.18% |
| Tower Research Capital LLCas of 30 Sep 2025 | 581.00 | 0.10% |
| BNP Paribas Financial Marketsas of 30 Sep 2025 | 230.00 | 0.04% |
| Bank of America, NA (Private Banking)as of 30 Sep 2025 | 5.00 | 0.00% |
| Clear Street LLCas of 30 Sep 2025 | 3.00 | 0.00% |
| BofA Securities, Inc.as of 30 Sep 2025 | 3.00 | 0.00% |
| Citigroup Global Markets, Inc. (Investment Management)as of 30 Sep 2025 | 1.00 | 0.00% |
| Danske Bank A/S (Investment Management)as of 30 Sep 2025 | 1.00 | 0.00% |
More ▼
Data from 30 Sep 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
